Welcome to our Q1, 2020 newsletter – part of a series that aims to provide a quarterly update of key regulatory issues affecting the UK/EU and the USA.
One topic dominates this edition – the response of firms, regulators and other industry participants to the spread of Covid-19 and its ramifications. We present a snapshot of developments at the time of writing, recognising that the situation is very fluid and additional near-term regulatory developments are highly likely.
We also contemplate the longer term implications of this crisis, including the legislative and regulatory response – caused not only by the impact of the virus itself, but also the potential economic fall-out to follow.
The newsletter is not exclusively Covid-19 focused. As usual we present a variety of regulatory developments, news items and enforcement cases. However, the spectre of Covid-19 looms over many of these. Regulatory initiatives might be revised, postponed or cancelled altogether. Among other things, stated timeframes for the implementation of a new requirement might be put back. Where the initiative emanates from the EU, there might be additional certainties for UK firms due to Brexit.
Amongst everything else going on, we hope that you enjoy reading our newsletter and that you find it helpful. If you have any feedback please share it with your consultant.